[Histonet] FW: [IHCRG] Very important question!!!!!!!!!!!!!!! !

[Houston, Ronnie]

Where did this come from?

The inclusion for Erbitux treatment depends on a POSITIVE reaction to the
DakoCytomation EGFR pharmDx, no more no less. There has never been any
discussion about grading the reaction either semi-quantitatively or
otherwise. 

I suggest that those grading their test results are not using this kit. Dako
make it very clear to their clients on how to interpret the test results.

Ronnie


Ronnie Houston
Director of Anatomic Pathology
Bon Secours HealthPartners Laboratories
5801 Bremo Road
Richmond, VA 23226
(804) 287 7972
(804) 287 7906 - fax
ronnie_houston <@t> bshsi.com 

-----Original Message-----
From: DDittus787 <@t> aol.com [mailto:DDittus787 <@t> aol.com]
Sent: Friday, March 05, 2004 4:47 PM
To: japoteete <@t> saintfrancis.com; Ronnie_Houston <@t> bshsi.com;
ploykasek <@t> phenopath.com; histonet <@t> pathology.swmed.edu
Subject: Re: [Histonet] FW: [IHCRG] Very important
question!!!!!!!!!!!!!!! !


not to second guess you,but i have been told (2days ago) that labs are not
reading results (kit or not) correctly and that this is not graded like her2
(even though it is called her1)so weak positivity is really positive not
neg, so studies should be done carefully.        dana






________________________________________________________________________________________________________________________________
________________________________________________________________________________________________________________________________

The information in this communication is intended to be confidential to the Individual(s) and/or Entity to whom it is addressed.
It may contain information of a Privileged and/or Confidential nature, which is subject to Federal and/or State privacy regulations.
In the event that you are not the intended recipient or the agent of the intended recipient, do not copy or use the information
contained within this communication, or allow it to be read, copied or utilized in any manner, by any other person(s).  Should
this communication be received in error, please notify the sender immediately either by response e-mail or by phone at 410-442-3250,
and permanently delete the original e-mail, attachment(s), and any copies.